How AI is transforming the way researchers conduct literature reviews: an interview with Peter O’Blenis, CEO, DistillerSR

Written by Peter O'Blenis (DistillerSR)
Artificial intelligence and machine learning Health data Interviews ISPOR Medical devices, pharmaceuticals and vaccines Methodology

Filmed at ISPOR Europe 2023 (Copenhagen, Denmark), Laura Dormer, Editor of The Evidence Base, speaks with Peter O’Blenis, CEO, DistillerSR, about how AI is transforming the way researchers conduct literature reviews.

You can view the entire video or view a specific question by entering ‘Fullscreen with Transcript’ or navigate via the ‘Visual Table of Contents’.

Questions:

  • 0:00: Please could you introduce yourself and give a brief overview of your career to date?
  • 0:36: Can you tell us more about DistillerSR and its mission? Why the specific focus on automation of literature reviews?
  • 2:15: How does DistillerSR use AI to automate the literature review and evidence generation process?
  • 3:46: What challenges in traditional literature review processes does AI aim to address?
  • 5:29: Can you share examples of case studies where DistillerSR has been used?
  • 6:45: How do you envisage the future of literature reviews with AI, and what innovations or improvements do you plan to introduce in the coming years?

 

 

Peter O’Blenis
CEO, DistillerSR

Peter is a pioneer in literature review automation. Having co-founded DistillerSR in 2009, he went on to demonstrate the first practical use of AI for reference screening at the Cochrane Colloquium in 2011. Prior to DistillerSR, Peter co-founded TrialStat, maker of the first commercially available systematic literature review platform. He holds an MBA from Queen’s University and a BSc in Computer Science from Carleton University.

 

You may also be interested in:

Medical AffairsUnlocking Medical Affairs’ hidden potential: AI at the helm

 

 

 

Sponsorship for this interview was provided by DistillerSR.